有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[[5-(cyclopropylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]acetamide | —— | C12H18N4O2S2 |
|
—— | 2-[(4-Chlorophenyl)methylsulfanyl]-5-piperidin-4-yl-1,3,4-oxadiazole | —— | C14H16ClN3OS |
|
—— | 2-[[5-(Cyclopropylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-(2,5-dimethylthiophen-3-yl)ethanone | —— | C13H15N3OS3 |
|
—— | N-(cyclohexen-1-yl)-2-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-(2-methoxyethyl)acetamide | —— | C20H26N4O2S2 |
|
—— | c-(5-Benzylsulfanyl-[1,3,4]oxadiazol-2-yl)-methylamine | —— | C10H11N3OS |
|
—— | [5-[(4-Fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]methylazanium | —— | C10H11FN3OS+ |
|
—— | (1S,2S)-1-(5-benzylsulfanyl-1,3,4-oxadiazol-2-yl)-2-methylbutan-1-amine | —— | C14H19N3OS |
|
—— | (5-Propan-2-ylsulfanyl-1,3,4-oxadiazol-2-yl)methanamine | —— | C6H11N3OS |
|
—— | [(1S,2S)-2-methyl-1-[5-[(2-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]butyl]azanium | —— | C15H22N3OS+ |
|
—— | 2-Ethylsulfanyl-5-piperidin-4-yl-1,3,4-oxadiazole | —— | C9H15N3OS |
|
—— | [(1S)-3-methyl-1-(5-propylsulfanyl-1,3,4-oxadiazol-2-yl)butyl]azanium | —— | C10H20N3OS+ |
|
—— | (1S,2S)-1-[5-[(2-chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylbutan-1-amine | —— | C14H18ClN3OS |
|
—— | [(1S,2S)-1-[5-[(2-chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]azanium | —— | C14H19ClN3OS+ |
|
—— | 3-(5-Benzylsulfanyl-1,3,4-oxadiazol-2-yl)propylazanium | —— | C12H16N3OS+ |
|
—— | [5-[(4-Chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]methanamine | —— | C10H10ClN3OS |
|
—— | (5-Propylsulfanyl-1,3,4-oxadiazol-2-yl)methanamine | —— | C6H11N3OS |
|
—— | 4-[5-(Benzylsulfanyl)-1,3,4-oxadiazol-2-YL]piperidine | —— | C14H17N3OS |
|
—— | 3-[5-[(4-Fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]propylazanium | —— | C12H15FN3OS+ |
|
—— | (1S,2S)-2-methyl-1-[5-[(3-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]butan-1-amine | —— | C15H21N3OS |
|
—— | (1S,2S)-1-[5-[(4-chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylbutan-1-amine | —— | C14H18ClN3OS |
|
—— | 2-Methylsulfanyl-5-piperidin-4-yl-1,3,4-oxadiazole | —— | C8H13N3OS |
|
—— | (1S,2S)-2-methyl-1-[5-[(2-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]butan-1-amine | —— | C15H21N3OS |
|
—— | 2-(5-Propylsulfanyl-1,3,4-oxadiazol-2-yl)ethylazanium | —— | C7H14N3OS+ |
|
—— | 2-[[5-(Cyclopropylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-[1-[(4-fluorophenyl)methyl]-2,5-dimethylpyrrol-3-yl]ethanone | —— | C20H21FN4OS2 |
|
—— | 2-[(4,5-dicyclopropyl-1,2,4-triazol-3-yl)sulfanyl]-1-(1H-pyrrol-2-yl)ethanone | —— | C14H16N4OS |
|
—— | (3S,5R)-3-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-5-methyloxolan-2-one | —— | C14H15N3O2S2 |
|
—— | (3R,5R)-3-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-5-methyloxolan-2-one | —— | C14H15N3O2S2 |
|
—— | (2S)-2-[(4-ethyl-5-oxo-1H-1,2,4-triazol-3-yl)sulfanyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]propanamide | —— | C15H19FN4O2S |
|
—— | 2-Cyclopropyl-5-[2-(trifluoromethyl)quinazolin-4-yl]sulfanyl-1,3,4-oxadiazole | —— | C14H9F3N4OS |
|
—— | N-[(3-chlorophenyl)methyl]-2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C17H17ClN4O2S |
|
—— | N-[(1R)-1-(3-chlorophenyl)ethyl]-3-(4-fluorophenyl)sulfanylpropanamide | —— | C17H17ClFNOS |
|
—— | 2-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N',N'-dimethylacetohydrazide | —— | C12H13ClN4O2S |
|
—— | 2-(4-bromophenyl)sulfanyl-N',N'-dimethylacetohydrazide | —— | C10H13BrN2OS |
|
—— | 1-(4-Butylphenyl)-3-[(2-phenylsulfanylacetyl)amino]thiourea | —— | C19H23N3OS2 |
|
—— | 2-[1-[(2S)-3-ethylpentan-2-yl]-4-oxopyrimidin-2-yl]sulfanylacetic acid | —— | C13H20N2O3S |
|
—— | (E)-3-[5-chloro-3-methyl-1-(2-methylpropyl)pyrazol-4-yl]-N'-[2-(4-methylphenyl)sulfanylacetyl]prop-2-enehydrazide | —— | C20H25ClN4O2S |
|
—— | N'-[2-(2-fluorophenyl)sulfanylacetyl]-5-methyl-3-phenyl-1,2-oxazole-4-carbohydrazide | —— | C19H16FN3O3S |
|
—— | 2-[1-[(2R)-3-ethylpentan-2-yl]-4-oxopyrimidin-2-yl]sulfanylacetic acid | —— | C13H20N2O3S |
|
—— | 3-methyl-N'-[2-(4-methylphenyl)sulfanylacetyl]-5-propan-2-yl-1,2-oxazole-4-carbohydrazide | —— | C17H21N3O3S |
|
—— | 3-ethyl-5-methyl-N'-[2-(4-methylphenyl)sulfanylacetyl]-1,2-oxazole-4-carbohydrazide | —— | C16H19N3O3S |
|
—— | 2-[(3S)-1,1-dioxothiolan-3-yl]-N'-[2-(2-fluorophenyl)sulfanylacetyl]acetohydrazide | —— | C14H17FN2O4S2 |
|
—— | 3-(2-chlorophenyl)-5-methyl-N'-[2-(4-methylphenyl)sulfanylacetyl]-1,2-oxazole-4-carbohydrazide | —— | C20H18ClN3O3S |
|
—— | 2-[(2-chlorophenyl)methylsulfanyl]-N'-[2-(4-methylphenyl)sulfanylacetyl]acetohydrazide | —— | C18H19ClN2O2S2 |
|
—— | (Z)-3-amino-2-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanylacetyl]but-2-enenitrile | —— | C12H9ClF3N3OS |
|
—— | [(Z)-1-methylsulfonylethylideneamino] N-methylcarbamate | —— | C5H10N2O4S |
|
—— | [(Z)-1-[(S)-methylsulfinyl]ethylideneamino] N-methylcarbamate | —— | C5H10N2O3S |
|
—— | [(Z)-1-[(R)-methylsulfinyl]ethylideneamino] N-methylcarbamate | —— | C5H10N2O3S |
|
—— | (Z)-3-amino-2-[2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetyl]but-2-enenitrile | —— | C14H11FN4O2S |
|
—— | 2-[(2R)-1-(2,2-dimethylpropyl)-4-[(2-methylsulfanylpyrimidin-5-yl)methyl]piperazin-2-yl]ethanol | —— | C17H30N4OS |
|
—— | N-(4-methylphenyl)-4-[[1-(thiophen-2-ylmethyl)tetrazol-5-yl]sulfanylmethyl]-1,3-thiazol-2-amine | —— | C17H16N6S3 |
|